TL;DR
This paper introduces a novel "tandem enrichment" strategy that simultaneously isolates N-glycopeptides and phosphopeptides from limited biological samples, significantly improving detection rates compared to separate enrichment methods. This approach is particularly valuable for clinical applications, such as lung cancer research, where sample quantity is often a bottleneck.
What Problem Does This Paper Address?
Proteins undergo various post-translational modifications (PTMs) that profoundly influence their function. Among the most common and biologically significant PTMs are N-glycosylation and phosphorylation. These modifications are crucial for understanding cellular processes, identifying disease biomarkers, and developing targeted therapies. However, both N-glycopeptides and phosphopeptides are present in very low abundances within complex biological samples like tissue biopsies. This low abundance, coupled with signal suppression from abundant unmodified peptides, makes their direct analysis by mass spectrometry extremely challenging.
Current methods typically involve enriching N-glycopeptides and phosphopeptides separately. This approach requires larger sample amounts, which are often unavailable in clinical settings. Furthermore, the separate enrichment process is time-consuming and can lead to peptide loss. Therefore, there's a critical need for a method that can efficiently and simultaneously enrich both N-glycopeptides and phosphopeptides from limited samples, improving throughput and sensitivity.
Methods
The core innovation of this study is a tandem enrichment strategy that combines two established enrichment techniques in a sequential manner:
- ZIC-HILIC (Zwitterionic Hydrophilic Interaction Liquid Chromatography): This method is used first to capture N-glycopeptides. The principle is that N-glycopeptides have a higher affinity for the HILIC stationary phase, while phosphopeptides and unmodified peptides flow through.
- TiO₂ Microparticles (Titanium Dioxide): The flow-through from the HILIC step, containing phosphopeptides and unmodified peptides, is then subjected to enrichment using TiO₂ microparticles. TiO₂ has a strong affinity for phosphopeptides, allowing for their selective capture. Unmodified peptides are washed away.
The key to the "tandem" aspect is that the flow-through and washing solutions from the N-glycopeptide enrichment step are directly used for phosphopeptide enrichment, minimizing sample loss and eliminating the need for intermediate drying or buffer exchange steps. This streamlined process is crucial for maximizing recovery from limited samples.
The enriched peptides are then analyzed using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). Data analysis involves searching against peptide databases using specialized software (Byonic for N-glycopeptides and MaxQuant for phosphopeptides) with specific parameters for PTM identification and localization.
Datasets
The primary dataset used for method development and validation was derived from HeLa cells. This provided a well-characterized biological matrix for optimizing the enrichment conditions and evaluating the method's performance.
For the application of the developed strategy, lung cancer tissue and normal lung tissue samples were used. This allowed the researchers to demonstrate the method's utility in a real-world clinical scenario, identifying differentially expressed N-glycopeptides and phosphopeptides between disease and healthy states.
Key Insights and Ideas
- Synergistic Enrichment: The tandem approach leverages the complementary binding properties of HILIC and TiO₂ to capture two distinct classes of PTMs in a single workflow, significantly increasing the overall yield of modified peptides.
- Sample Conservation is Key: The strategy's design prioritizes minimizing sample loss at each step, making it exceptionally well-suited for precious clinical samples where every microgram counts.
- Streamlined Workflow: By directly using the flow-through from the first enrichment step for the second, the method eliminates laborious intermediate steps, saving time and reducing the risk of sample degradation or loss.
- Enhanced Sensitivity: The combined enrichment leads to a substantial increase in the number of identified N-glycopeptides and phosphosites compared to separate enrichment, revealing a deeper layer of proteomic information.
- Clinical Relevance: The successful application to lung cancer tissue demonstrates the method's power in identifying biologically relevant differences between disease and normal states, paving the way for biomarker discovery.
Key Results
- Increased Peptide Yield: The tandem enrichment strategy identified 21%-377% more N-glycopeptides and 22%-263% more phosphosites compared to separate enrichment methods, using the same starting peptide amounts (160-20 µg).
- HeLa Cell Profiling: Under optimized conditions, 2798 N-glycopeptides from 434 N-glycoproteins and 5130 phosphosites from 1986 phosphoproteins were confidently identified from HeLa cells in three technical replicates.
- Reproducibility: The method demonstrated good identification and quantification reproducibility for both N-glycopeptides and phosphopeptides across technical replicates.
- Lung Cancer Application: In lung cancer tissue analysis, the strategy identified hundreds of differentially expressed N-glycosylated and phosphorylated proteins between cancer and normal tissues, with hundreds of differentially expressed N-glycopeptides and phosphosites.
- Sample Reduction Advantage: The tandem approach showed a significant advantage with lower starting peptide amounts, achieving 3.7-fold and 2.6-fold enhancement for N-glycopeptides and phosphosites, respectively, when using only 20 µg of peptides.
Limitations and Future Work
- Optimization for Specific Samples: While the method was optimized using HeLa cells and applied to lung cancer tissue, further optimization might be necessary for other complex biological matrices.
- Unmodified Peptide Interference: Although TiO₂ enrichment aims to remove unmodified peptides, some residual interference might still occur, potentially impacting sensitivity for very low abundance PTMs.
- Future Directions: The authors suggest that this tandem enrichment strategy holds significant potential for clinical applications, including biomarker discovery and drug target identification, especially in studies involving limited sample sizes. Further exploration of its application to other PTMs or sample types could also be beneficial.
Summary updated